New oral drugs show promise for the treatment of multiple sclerosis

被引：0
|
作者：
不详
机构：
来源：
FUTURE MEDICINAL CHEMISTRY | 2010年 / 2卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：308 / 308
页数：1
相关论文
共 50 条
  • [21] The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations
    Irene Eriksson
    Joris Komen
    Fredrik Piehl
    Rickard E. Malmström
    Björn Wettermark
    Mia von Euler
    European Journal of Clinical Pharmacology, 2018, 74 : 663 - 670
  • [22] The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations
    Eriksson, Irene
    Komen, Joris
    Piehl, Fredrik
    Malmstrom, Rickard E.
    Wettermark, Bjorn
    von Euler, Mia
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (05) : 663 - 670
  • [23] Drugs Treatment of Pain in Multiple Sclerosis
    Siniscalchi, Antonio
    Gallelli, Luca
    De Sarro, Giovambattista
    CURRENT CLINICAL PHARMACOLOGY, 2007, 2 (03): : 227 - 233
  • [24] NEW MEDICATIONS SHOW PROMISE AS ACNE ROSACEA TREATMENT
    GREER, KE
    POSTGRADUATE MEDICINE, 1985, 77 (08) : 35 - 35
  • [25] The use of disease-altering new drugs for multiple sclerosis treatment
    Ozminkowski, RJ
    Marder, W
    Hawkins, K
    Wang, S
    Stallings, S
    Finkelstein, S
    Sinskey, A
    Wierz, D
    VALUE IN HEALTH, 2003, 6 (03) : 273 - 273
  • [26] Impact of new drugs and treatment recommendations on drug utilization in multiple sclerosis
    Eriksson, Irene
    Komen, Joris
    Piehl, Fredrik
    Malmstrom, Rickard E.
    Wettermark, Bjorn
    von Euler, Mia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 214 - 214
  • [27] New and emerging immune-targeted drugs for the treatment of multiple sclerosis
    Palmer, Alan M.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (01) : 33 - 43
  • [28] MULTIPLE SCLEROSIS Closing in on an oral treatment
    Martin, Roland
    NATURE, 2010, 464 (7287) : 360 - 362
  • [29] Oral laquinimod treatment in multiple sclerosis
    Fernandez, O.
    NEUROLOGIA, 2011, 26 (02): : 111 - 117
  • [30] From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis
    Aly, Lilian
    Hemmer, Bernhard
    Korn, Thomas
    CURRENT NEUROPHARMACOLOGY, 2017, 15 (06) : 874 - 891
12345